| Alkaloid (11) |  |
| Allergan (6) | |
| Astrazeneca (7) | |
| Basi (302) | |
| Bayer (10) | |
| F hoffmann la roche ltd (24) | |
| Glaxosmithkline (15) | |
| Novartis (22) | |
| Pfizer (10) | |
| Sanofi (5) | |
| Alkaloid (11) | |
| Allergan (6) | |
| Astrazeneca (7) | |
| Basi (302) | |
| Bayer (10) | |
| F hoffmann la roche ltd (24) | |
| Glaxosmithkline (15) | |
| Novartis (22) | |
| Pfizer (10) | |
| Sanofi (5) | |
#The research was funded by the National institutes of health the Packard Award in Science and Engineering Sanofi Pharmaceuticals Foxconn Technology Group and the Hertz Foundation e
and even high cholesterol in its development pipeline and has three in human trials progress that led the pharmaceutical company Sanofi to make a $700 million investment in the company last winter.
Astellas, Bayer, Boehringer ingelheim, Glaxosmithkline, Lilly, Novartis, Roche, Sanofi, Takeda, UCB, and Viiv Healthcare. Three industry groupspharmaceutical Research and Manufacturers of America (Phrma), the European Federation of Pharmaceutical industries and Associations (EFPIA),
Zaltrap developer Sanofi responded with 50%discounts while maintaining its official price. A year later, some 120 investigators and other experts in chronic myeloid leukemia (CML) publicly demanded lower cancer drug prices.
"Church says, pointing to an episode at Genzyme Corp.,a Cambridge, Mass.,pharmaceutical manufacturer, in 2009.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011